Zimmer Biomet Holdings Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Zimmer Biomet Holdings ha aumentado sus beneficios a una tasa media anual de 35.5%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 10.6% anual. Los ingresos han ido disminuyendo a una tasa media de 2.3% al año. La rentabilidad financiera de Zimmer Biomet Holdings es de 8.2%, y sus márgenes netos son de 13.8%.

Información clave

32.0%

Tasa de crecimiento de los beneficios

31.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	12.9%
Tasa de crecimiento de los ingresos	-1.6%
Rentabilidad financiera	7.7%
Margen neto	12.9%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Zimmer Biomet Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

BMV:ZBH * Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	7,452	964	2,816	456
31 Dec 23	7,394	1,024	2,793	459
30 Sep 23	7,279	474	2,768	453
30 Jun 23	7,196	506	2,757	438
31 Mar 23	7,108	450	2,727	420
31 Dec 22	6,940	290	2,668	406
30 Sep 22	6,892	366	2,649	394
30 Jun 22	6,908	334	2,632	386
31 Mar 22	6,889	325	2,631	452
31 Dec 21	6,827	445	2,626	436
30 Sep 21	7,135	834	2,787	440
30 Jun 21	7,379	914	2,915	432
31 Mar 21	6,842	563	2,886	355
31 Dec 20	6,128	-11	2,524	323
30 Sep 20	7,065	-152	3,030	393
30 Jun 20	7,028	37	3,042	422
31 Mar 20	7,791	377	3,221	446
31 Dec 19	7,982	1,132	3,279	449
30 Sep 19	7,928	-90	3,331	429
30 Jun 19	7,872	-359	3,299	411
31 Mar 19	7,891	-308	3,268	398
31 Dec 18	7,933	-379	3,372	392
30 Sep 18	7,930	1,753	3,119	386
30 Jun 18	7,907	1,690	3,071	381
31 Mar 18	7,849	1,689	3,029	375
31 Dec 17	7,803	1,814	3,096	370
30 Sep 17	7,748	652	2,988	371
30 Jun 17	7,768	712	3,012	375
31 Mar 17	7,752	497	2,972	371
31 Dec 16	7,668	306	2,906	366
30 Sep 16	7,604	363	2,900	356
30 Jun 16	7,534	227	2,865	344
31 Mar 16	6,767	84	2,577	306
31 Dec 15	5,998	147	2,284	269
30 Sep 15	5,287	174	2,000	229
30 Jun 15	4,631	325	1,730	192
31 Mar 15	4,646	670	1,730	188
31 Dec 14	4,673	720	1,751	187
30 Sep 14	4,691	802	1,789	188
30 Jun 14	4,659	784	1,804	191
31 Mar 14	4,646	764	1,818	198
31 Dec 13	4,623	780	1,749	203
30 Sep 13	4,563	678	1,817	213
30 Jun 13	4,514	702	1,809	217

Ingresos de calidad: ZBH * tiene un gran one-off loss de $276.9M impacto en sus últimos 12 meses de resultados financieros a 31st March, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio (13.8%) de ZBH * son superiores a los del año pasado (4.2%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: ZBH * ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 35.5% al año.

Acelerando crecimiento: El crecimiento de los beneficios de ZBH * en el último año (252.9%) supera su media de 5 años (35.5% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de ZBH * en el último año (252.9%) superó al de la industria Medical Equipment -1.1%.

Zimmer Biomet Holdings Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Información clave

Actualizaciones de resultados anteriores recientes

Zimmer Biomet Holdings, Inc. to Report Q1, 2024 Results on May 02, 2024

Full year 2023 earnings released: EPS: US$4.91 (vs US$1.39 in FY 2022)

Zimmer Biomet Holdings, Inc. to Report Q4, 2023 Results on Feb 08, 2024

Third quarter 2023 earnings released: EPS: US$0.78 (vs US$0.93 in 3Q 2022)

Zimmer Biomet Holdings, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Second quarter 2023 earnings released: EPS: US$1.01 (vs US$0.73 in 2Q 2022)

Recent updates

Zimmer Biomet Holdings, Inc. Reiterates Financial Guidance for Current Full-Year 2024

Zimmer Biomet Holdings, Inc. to Report Q1, 2024 Results on May 02, 2024

Zimmer Biomet Holdings, Inc., Annual General Meeting, May 10, 2024

Upcoming dividend of US$0.24 per share

Fourth quarter dividend of US$0.24 announced

Full year 2023 earnings released: EPS: US$4.91 (vs US$1.39 in FY 2022)

Fourth quarter dividend of US$0.24 announced

Zimmer Biomet Holdings, Inc. Announces U.S. Food and Drug Administration (FDA) 510(K) Clearance of the Rosa® Shoulder System for Robotic-Assisted Shoulder Replacement Surgery

Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for the First Quarter of 2024, Payable on or About April 30, 2024

Zimmer Biomet Holdings, Inc. Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting

Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year 2024

Zimmer Biomet Holdings, Inc. to Report Q4, 2023 Results on Feb 08, 2024

Zimmer Biomet Holdings, Inc. Announces Appointment of Louis A. Shapiro to Board of Directors

Zimmer Biomet Holdings, Inc. Approves Cash Dividend for the Fourth Quarter of 2023, Payable on or About January 31, 2024

Third quarter 2023 earnings released: EPS: US$0.78 (vs US$0.93 in 3Q 2022)

Zimmer Biomet Holdings, Inc. Updates Revenue Guidance for the Year Ending December 31, 2023

Zimmer Biomet Holdings, Inc. Updates Revenue Guidance for the Year Ending December 31, 2023

Zimmer Biomet Holdings, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.24 per share at 0.8% yield

Independent Director recently bought Mex$1.9m worth of stock

Zimmer Biomet Holdings, Inc. Announces Quarterly Dividend for Third Quarter of 2023, Payable on or about October 31, 2023

Zimmer Biomet Holdings, Inc. Announces CEO Changes

Second quarter 2023 earnings released: EPS: US$1.01 (vs US$0.73 in 2Q 2022)

Zimmer Biomet Holdings, Inc. Revises Earnings Guidance for the Year 2023

Zimmer Biomet Holdings, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Upcoming dividend of US$0.24 per share at 0.7% yield

Insufficient new directors

Insufficient new directors

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2023, Payable on July 31, 2023

First quarter 2023 earnings released: EPS: US$1.11 (vs US$0.35 in 1Q 2022)

Upcoming dividend of US$0.24 per share at 0.8% yield

Full year 2022 earnings released: EPS: US$1.39 (vs US$2.13 in FY 2021)

Insufficient new directors

Full year 2022 earnings released: EPS: US$1.39 (vs US$1.93 in FY 2021)

Zimmer Biomet Holdings, Inc. Reports Unaudited Impairment Charges for the Fourth Quarter Ended December 31, 2022

Zimmer Biomet Holdings, Inc. to Report Q4, 2022 Results on Feb 03, 2023

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) entered into a definitive agreement to acquire Embody, Inc. for approximately $300 million.

Insufficient new directors

Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2022, Payable on or About January 31, 2023

Insufficient new directors

Zimmer Biomet Holdings, Inc. Expands Persona(R) Knee System Portfolio with FDA Clearance of Persona(R) Osseoti(R) Keel Tibia for Cementless Knee Replacement

Insufficient new directors

Zimmer Biomet Holdings, Inc. Announces One-Year Data from mymobility® Clinical Study at 2022 AAHKS Annual Meeting

Third quarter 2022 earnings released: EPS: US$0.93 (vs US$0.70 in 3Q 2021)

Zimmer Biomet Holdings, Inc. Updates Financial Guidance for the Year Ending December 31, 2022

Zimmer Biomet Holdings, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Upcoming dividend of US$0.24 per share

Zimmer Biomet Holdings, Inc. Receives FDA Clearance for Identity(TM) Shoulder System for Shoulder Replacement

Zimmer Biomet Holdings, Inc Approves Quarterly Cash Dividend, Payable on or About October 31, 2022

Second quarter 2022 earnings released: EPS: US$0.73 (vs US$0.68 in 2Q 2021)

Zimmer Biomet Holdings, Inc. Revises Earnings Guidance for the Year Ending December 31, 2022

Zimmer Biomet Holdings, Inc. to Report Q2, 2022 Results on Aug 02, 2022

Upcoming dividend of US$0.24 per share

Now 20% undervalued after recent price drop

Zimmer Biomet Holdings, Inc. Appoints Keri P. Mattox as Chief Communications and Administration Officer

Zimmer Biomet Holdings, Inc. Approves Quarterly Dividend for Second Quarter of 2022, Payable on or About July 29, 2022

Zimmer Biomet Holdings, Inc. Debuts First-Of-Its-Kind Artificial Intelligence Capabilities for Omni™ Suite Intelligent Operating Room

Now 20% undervalued

Zimmer Biomet Holdings, Inc. Revises Earnings Guidance for the Year Ending December 31, 2022

First quarter 2022 earnings released: EPS: US$0.93 (vs US$0.95 in 1Q 2021)

Insufficient new directors

Extremity Medical, LLC Files Patent Infringement Lawsuit Against Nextremity Solutions, Zimmer Biomet Holdings, Inc. and Zimmer, Inc

Zimmer Biomet Holdings, Inc. to Report Q1, 2022 Results on May 03, 2022

Upcoming dividend of US$0.24 per share

Zimmer Biomet Holdings, Inc., Annual General Meeting, May 16, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2022

Insufficient new directors

Group President of Asia Pacific recently sold Mex$7.4m worth of stock

Desglose de ingresos y gastos
Beta